🔎 Trials Near Me

Home › Acute Biphenotypic Leukemia

Acute Biphenotypic Leukemia clinical trials recruiting in the U.S.

38 studies for Acute Biphenotypic Leukemia are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04797767

Personalized NK Cell Therapy in CBT

RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Nov 2, 2026 · NCT02727803

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

RecruitingPhase 1/2Healthy volunteers welcome
Up to age 50 · All sexes · Updated Oct 30, 2026 · NCT05322850

Prophylactic DLI-X for Leukemia Relapse After HCT

RecruitingPhase 1
Up to age 65 · All sexes · Updated Oct 29, 2026 · NCT07254793

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 28, 2026 · NCT01137643

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
Ages 13 to 90 · All sexes · Updated Oct 26, 2026 · NCT06533579

A Study of Revumenib and Mezigdomide in People With Leukemia

RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 20, 2026 · NCT07356154

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

RecruitingPhase 1
Ages 2 and older · All sexes · Updated Oct 19, 2026 · NCT06575296

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
30 Days · All sexes · Updated Oct 9, 2026 · NCT04065399

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RecruitingPhase 1
Ages 12 to 78 · All sexes · Updated Sep 29, 2026 · NCT03802695

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT03683433

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

RecruitingPhase 4
Ages 1 to 18 · All sexes · Updated Jul 14, 2026 · NCT06289673

Allo HSCT Using RIC and PTCy for Hematological Diseases

RecruitingPhase 2
Up to age 75 · All sexes · Updated Jul 6, 2026 · NCT05805605

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.